Abstract: Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.
Type:
Grant
Filed:
December 18, 2013
Date of Patent:
November 13, 2018
Assignee:
Qualitas Health, Ltd.
Inventors:
Brian J. Waibel, Hans Schonemann, Val Krukonis, Michael Kagan
Abstract: Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.
Type:
Grant
Filed:
April 21, 2017
Date of Patent:
August 7, 2018
Assignee:
Qualitas Health, Ltd.
Inventors:
Brian J. Waibel, Hans Schonemann, Val Krukonis, Michael Kagan
Abstract: Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.
Type:
Application
Filed:
April 21, 2017
Publication date:
October 26, 2017
Applicant:
Qualitas Health, Ltd.
Inventors:
Brian J. WAIBEL, Hans SCHONEMANN, Val KRUKONIS, Michael KAGAN
Abstract: Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.
Type:
Grant
Filed:
March 12, 2013
Date of Patent:
April 25, 2017
Assignee:
Qualitas Health, Ltd.
Inventors:
Brian J. Waibel, Hans Schonemann, Val Krukonis, Michael Kagan
Abstract: Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.
Type:
Application
Filed:
December 18, 2013
Publication date:
February 9, 2017
Applicant:
Qualitas Health, Ltd.
Inventors:
Brian J. WAIBEL, Hans SCHONEMANN, Val KRUKONIS, Michael KAGAN